Related Experiment Video
Updated: Aug 9, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
Prophylactic hemodialysis does not prevent contrast-induced nephropathy after cardiac catheterization in patients
Shuji Kawashima1, Hitoshi Takano, Yasuhiko Iino
1First Department of Internal Medicine, Nippon Medical School, Tokyo, Japan.
Insights
Prophylactic hemodialysis does not prevent contrast-induced nephropathy (CIN) in patients with chronic renal insufficiency (CRI). This study found no benefit and potential harm in certain patient groups undergoing cardiac catheterization.
Area of Science:
- Nephrology
- Cardiology
- Radiology
Background:
- Contrast-induced nephropathy (CIN) is a risk following cardiac catheterization.
- Prophylactic hemodialysis is a debated strategy for CIN prevention in Japan.
- Chronic renal insufficiency (CRI) increases CIN risk.
Purpose of the Study:
- To evaluate the efficacy of prophylactic hemodialysis in preventing CIN.
- To assess CIN incidence in CRI patients undergoing cardiac catheterization.
- To compare outcomes between hydration and hemodialysis strategies.
Main Methods:
- Retrospective analysis of 391 CRI patients undergoing cardiac catheterization.
- Patients categorized by serum creatinine (Scr) levels: L, M, and H.
- Comparison of CIN incidence in patients receiving hydration versus hemodialysis.
Main Results:
- CIN developed in 48 patients; incidence was highest in the high Scr (H) category (40%).
- In moderate Scr (M) patients, hemodialysis increased Scr and CIN incidence (29%) compared to hydration (11%).
- Hydration alone did not alter Scr or increase CIN in M category patients.
Conclusions:
- Prophylactic hemodialysis does not prevent CIN in CRI patients.
- Hemodialysis may increase CIN risk in certain CRI patient subgroups.
- Current evidence does not support prophylactic hemodialysis for CIN prevention in this population.
Background:
In Japan, prophylactic hemodialysis has been considered useful for preventing contrast-induced nephropathy (CIN).
Method And Results:
To assess whether hemodialysis prevented CIN, 391 patients (age: 69 +/- 8 years, 63 females) with chronic renal insufficiency (CRI, serum creatinine level (Scr) > or = 1.3 mg/dl) who underwent cardiac catheterization, were retrospectively analyzed. Patients were divided into 3 categories based on Scr: L (1.3 > or = Scr < 2.0 mg/dl, n = 332); M (2.0 > or = Scr < 3.0 mg/dl, n = 49); and H (Scr > or = 3.0 mg/dl, n = 10). To prevent CIN, 35 category M patients and all category L patients received hydration alone, whereas 14 category M patients and all category H patients received hemodialysis. CIN developed in 48 patients. The incidence of CIN in category H was significantly higher than that in category L or M (H, 40% vs L, 11% or M, 16% (p < 0.05)). In category M patients treated with hemodialysis, Scr increased from 2.4 +/- 0.3 to 3.0 +/- 0.5 mg/dl (p < 0.05) within 7 days, and 29% of patients developed CIN. However, in category M patients who did not receive hemodialysis, the Scr did not change (pre, 2.3 +/- 0.2 mg/dl to post, 2.2 +/- 0.4 mg/dl), and the incidence of CIN was 11%.
Conclusion:
Prophylactic hemodialysis for CRI patients undergoing cardiac catheterization does not prevent CIN.
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Cardiac Catheterization IV: Nursing Management
Imaging Studies VII: Vascular Imaging
Hemodialysis II: Procedure and Complications
Hemodialysis III: Nursing Management
